the same analysis , applied to patients in whom s-beta-2m was available at presentation , selected s-beta-2m , s-creatinine and percentage of bone marrow plasma cells ( accounting for 92 % of total chi 2 ) , followed by platelet count , s-albumin and s-m-component .
C0229671
s-beta-2m
C0032105
plasma